Comparison of Patient Outcomes Before and After Switching From Warfarin to a Direct Oral Anticoagulant Based on Time in Therapeutic Range Guideline Recommendations.
Document Type
Article
Publication Date
7-1-2022
Publication Title
JAMA Network Open
Abstract
This cohort study evaluates stroke and major bleeding rates before and after switching from warfarin to a direct oral anticoagulant (DOAC) in patients grouped by pre-switch time-in-therapeutic range guideline thresholds.
Volume
5
Issue
7
First Page
2222089
Last Page
2222089
Recommended Citation
Haymart B, Barnes GD, Kong X, Ali M, Kline-Rogers E, DeCamillo D, et al Comparison of patient outcomes before and after switching from warfarin to a direct oral anticoagulant based on time in therapeutic range guideline recommendations. JAMA Netw Open. 2022 Jul 1;5(7):e2222089. doi: 10.1001/jamanetworkopen.2022.22089. PMID: 35834255.
DOI
10.1001/jamanetworkopen.2022.22089
ISSN
2574-3805
PubMed ID
35834255
COinS